| | | |   | | | | By Ed Silverman SAUL LOEB/AFP/Getty Images "This is a pond in which there are some pretty big fish that can be caught,” said David Balto, a former FTC policy director. Read More | | By Nicholas Florko Mario Tama/Getty Images The FDA is pulling Juul products off the market, citing "potentially harmful chemicals leaching from the company's proprietary e-liquid pods" Read More | | By Nicholas Florko Sarah Silbiger/Getty Images While lowering nicotine levels in cigarettes would be a massive deal, the FDA this week only took a first, very small step, toward that goal. Read More | | Sponsor content by REGULATORY AFFAIRS PROFESSIONALS SOCIETY (RAPS) Is understanding the practical applications of regulatory requirements critical to your job? Get up-to-date knowledge of new regulations and their implications for pharmaceutical and biologics regulatory affairs with a Regulatory Affairs Certificate in pharmaceuticals from RAPS. Delve into the latest information with self-paced online courses covering issues associated with bringing drugs to market and the regulatory profession. The certificate program features a curriculum of four core courses and five electives, chosen from dozens of options spanning the topical areas of quality, clinical, biologics, and pharmaceuticals. Learn more. | | By Damian Garde and Meg Tirrell and Adam Feuerstein This episode we discuss the FDA's decision to ban the sale of Juul Labs and a rumored blockbuster buyout in biotech. Read More | |
No comments